Objective To measure changes in range of motion (ROM) over time in a cohort of 55 adolescents and young adults with chronic fatigue syndrome and to determine whether changes in ROM correlated with changes in healthrelated quality of life.
Results
The mean age at enrollment was 16.5 years (range [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] . Two-year follow-up was available for 53 (96%).
The proportion with a ROM score of >2 fell gradually over 2 years, from 78% at entry to 20% at 24 months (P < .001). ROM scores improved from a median of 5 at entry to 2 at 24 months (P < .001). The change in the summed degrees of improvement in ROM correlated positively with improvement in the PedsQL physical function subscale (r = 0.30; P < .03). P ediatric chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis or myalgic encephalomyelitis/CFS, is a relatively common and often disabling disorder of uncertain etiology. [1] [2] [3] [4] [5] [6] [7] [8] The illness is characterized by profound fatigue lasting at least 6 months, a characteristic worsening of symptoms after physical or cognitive exertion (termed postexertional malaise), and other common symptoms including headache, unrefreshing sleep, lightheadedness, cognitive dysfunction, myalgias, joint pain, and less commonly sore throat and tender glands. The onset of symptoms can be abrupt, following an infectious illness such as mononucleosis, 9 or gradual. The illness is less common before adolescence, 5 and occurs 2-4 times more commonly among female individuals. 3, [5] [6] [7] Pediatric CFS is strongly associated with circulatory disorders such as postural tachycardia syndrome and neurally mediated hypotension, [10] [11] [12] [13] [14] [15] and with joint hypermobility or Ehlers-Danlos syndrome. 16, 17 Recent research has demonstrated a higher prevalence of restrictions in symptom-free range of motion (ROM) among individuals with CFS. [18] [19] [20] In a study of 48 adolescents and young adults with CFS and 48 healthy controls matched for sex and degree of joint hypermobility, those with CFS had a higher median number of areas with impaired ROM (5 vs 2; P < .001) and were more likely to have greater than 3 areas of impaired ROM (OR 6.0; 95% CI 2.1-17.3; P < .001). 19 Performing the ROM examination was more likely to provoke increased fatigue and other abnormal symptomatic responses in those with CFS (40 vs 4%; P < .001). 19 Subsequent work has shown that in response to a 15-minute passive straight leg raise maneuver, individuals with CFS develop an increased intensity of CFS symptoms immediately and for at least 24 hours afterward, 20 consistent with the hypothesis that increased sensitivity to neuromuscular mechanical strain is a mechanism of symptom provocation in the illness. 18 Because these observations are relatively new, little is known about the course of ROM abnormalities over time. The Johns Hopkins CFS Cohort Study was designed in part to assess whether these ROM impairments were static or changed over time, examine the pace of change in association with multimodal therapy and determine whether changes in ROM correlated with changes in overall function. 2 Full inclusion and exclusion criteria are described elsewhere. 19 Participants were followed and treated clinically for 2 years. The study was approved by the Institutional Review Board of the Johns Hopkins Medical Institutes. Written informed consent was obtained from participants 18 years of age and over; parents of younger children provided written, informed consent, and those younger than 18 years of age also provided verbal assent.
Conclusions

CFS
Physical Examinations and Definitions of Abnormal Tests
All participants had a general physical examination that included the 9-point Beighton score, a commonly used, reliable measure of joint hypermobility. 21 Participants were assessed for neurodynamic dysfunction and ROM using the following maneuvers commonly used in physical therapy practice: seated slump testing, ankle dorsiflexion, passive straight leg raise, the upper limb neurodynamic test (also known as the upper limb tension test with a median nerve bias), prone knee bend, and prone press-up. Methods for performing the examination maneuvers have been described in detail elsewhere. 19 The definition of abnormal ROM for each test is shown in Table I . The sum of the dichotomized ROM scores (normal = 0/abnormal = 1) for prone press-up and for each limb of the other 5 measures formed a composite ROM score, with possible values ranging from 0 to 11. All testing was performed by a single experienced general pediatrician after >20 hours of training with the study physical therapist. Goniometers were used to measure ROM for all measures except the prone press-up.
Treatment
Participants returned for clinical care as indicated (more frequently in the first 6-12 months until treatment regimens were stable) as well as for repeat ROM examinations and questionnaire completion at approximately 3-to 6-month intervals for the 24 months of the study. The treatments involved multimodal therapy directed at individual symptoms and specific comorbid conditions (including orthostatic intolerance, insomnia, headaches, myalgias, pain, dysmenorrhea, inhalant allergies, and food allergies), tailored to the specific needs of each individual. When ROM impairments were observed at enrollment, we most often recommended manual physical therapy techniques, especially early in the course of treatment. However, the form of therapy was not standardized and treatment methods were at the discretion of the individual's physical therapist.
Study Measures
All participants completed the Pediatric Quality of Life Inventory 4.0 (PedsQL), a brief, multidimensional child selfreport instrument for measuring health-related quality of life, available in age-appropriate formats (Child Report for ages 8-12 years, Teen Report for ages 13-18 years, or Young Adult for ages 18-24 years). 22 The 23-item assessment examines the child's health and activities, feelings, ability to get along with others (which includes social relations as well as stamina), and school functioning (which includes measures of cognition as well as attendance). The total score ranges from 0 to 100, with higher scores indicating better quality of life. Subscales of the PedsQL measure physical, emotional, social, and school functioning. This instrument is reliable, valid, and has been used widely in pediatric chronic illness populations, including CFS. 3, 7, 23, 24 Statistical Analyses Normally distributed continuous data were compared using paired t tests. We used the Wilcoxon signed-rank tests for ordinal and interval level data when comparing paired changes in range of motion over 24 months for each participant. For nominal level data, paired data were analyzed using the McNemar test. Life table methods were used to analyze the time until the ROM score was ≤2, the median score for healthy individuals in the cross-sectional study at baseline. The change in ROM score between baseline and 24 months was analyzed using the Wilcoxon signed-rank test.
The change in the PedsQL total and subscale scores was obtained by subtracting the 24-month PedsQL score from the score at study entry; positive results indicate improvement in the PedsQL, and negative results worsening from baseline to 24 months. To obtain a continuous measure of change in ROM we summed the changes in ROM on the 10 tests (excluding the prone press-up, which was a categorical variable). For example, an individual with 2 degrees of improvement in seated slump testing on the left side and 2 degrees on the right, 5 
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Results
Participants
We enrolled 55 consecutive participants with CFS from October 2008 to December 2012. The mean (SD) ages at onset of CFS and at enrollment in the study were 13.3 (2.8) and 16.5 (2.1) years respectively, with an age range at enrollment of 10-23 years. Forty-six (84%) were female and 95% were white. The onset of CFS was gradual in 40% and abrupt in 60%. The mean (SD) body mass index (BMI) was 22.5 (4.0). The median Beighton score was 4 (range 0-8).
Treatment
Over the first 6 months of the study, 60% were treated by a physical therapist for varying intervals of time. In all, 93% were treated by physical therapists at some point over the 2 years of the study.
Changes in ROM
Data from all 55 participants were included in the life table analysis that examined the changes in the 0-11 ROM score over time. As shown in Figure 1 , the ROM scores improved gradually over the 24 months of study. Of the original 55 participants, 78% had an ROM score ≥3 at study entry compared with 20% at 24 months. The median time to a ROM score ≤2
(the median score for healthy controls in the earlier study) was 7.7 months. Two individuals whose CFS symptoms had improved substantially by 6 months elected not to return for further follow-up, leaving 53 of 55 (96%) of the cohort with complete 24-month data. Table II displays the proportion with abnormal ROM scores on each examination maneuver at baseline and at 24 months. Of the 11 examination maneuvers, 8 were significantly improved at 24 months compared with baseline. The largest changes were evident in the passive straight leg raise and upper limb neurodynamic test range of motion, reflecting improvement in measures of adverse neural tension or neurodynamic function. For example, the proportion with abnormal scores on the straight leg raise fell from 68% on the left and 70% on the right at baseline to 13% on each side at 24 months. Figure 2 displays the distribution of composite ROM scores at baseline and 24 months. The median ROM score was 5 at baseline and 2 at 24 months (P < .001, Wilcoxon signed-rank test).
The PedsQL subscale and total scores at study entry improved significantly over time (Table III ; available at www.jpeds.com). As shown in Figure 3 (available at www.jpeds.com), the cumulative change in ROM in degrees over 24 months correlated positively with the PedsQL physical function subscale score (r = 0.30; P = < .03). Nonsignificant correlations were seen with the PedsQL total score (r = .24; P = .08), and with the emotional (r = .08; P = .6), social (r = 0.22; P = .12), and school (r = 0.22; P = .12) function subscales.
Of the 53 participants with 24-month data, 43 experienced an improvement in ROM scores, and 10 did not. Of the 10 who were unimproved, 3 had ROM scores of 0 at baseline and, thus, had no opportunity to demonstrate improvement using this study measure; 4 had no change in ROM scores, and 3 experienced a 2-point worsening in ROM scores. Statistical comparisons between the 3 whose ROM scores worsened and the 50 who were unchanged or improved were not possible because of the small number of unimproved individuals. .13 Straight leg raise (left) <45 degrees at stretch onset 68% 13% <.001 Straight leg raise (right) <45 degrees at stretch onset 70% 13% <.001 ULNT (left) <170 degrees at stretch onset 74% 36% <.001 ULNT (right) <170 degrees at stretch onset 64% 28% <.001 Prone knee bend (left) <130 degrees at stretch onset 45% 23% <.01 Prone knee bend (right) <130 degrees at stretch onset 36% 15% <.01 Prone press-up abnormal 55% 28% .001
*The proportions represent the prevalence of abnormal ROM on the individual measures at the 2 time points for the 53 participants who were available for the entire 24 months. †For each maneuver, the statistical comparisons of the paired data (dichotomized as normal/ abnormal) were performed using the McNemar test.
To explore whether changes in the ROM over time were related to the baseline level of joint hypermobility, we dichotomized the 53 with 24 month data into those with a Beighton score of 0-3 (normal; n = 26) vs ≥4 (hypermobile; n = 27). The median ROM score at the onset of stretch was 5 for both groups (P = .66). The median change in ROM score (baseline minus 24 month score) was 3 for both groups (P = .82). The mean total change in ROM was 94 (68) vs 114 (79) degrees for the normal and hypermobile groups respectively, P = .35.
Discussion
Among adolescents and young adults with CFS, impaired range of motion in the limbs and spine noted at study enrollment improved significantly in association with multimodal treatment over 24 months of follow-up. Improvement in range of motion correlated with improvement in scores on the physical function subscale of a validated measure of healthrelated quality of life, the PedsQL.
The correlation between the PedsQL physical function score, and the cumulative improvement in ROM was relatively modest, as might be expected for a disorder with as much clinical heterogeneity as CFS. Nonetheless, these results are in the expected direction. CFS symptom intensity is increased by short-term challenges that add elongation strain to the muscles, fascia, spinal cord, peripheral nerves, and perineural soft tissues. [16] [17] [18] Based on these findings, one would predict that improvement in neural and soft tissue ROM would be associated with lower symptom intensity and improved overall function. The findings of this follow-up study support the hypothesis that there is reduced compliance in the neuromuscular system in individuals with CFS and are consistent with the hypothesis that increased mechanosensitivity is a modifiable contributor to the generation of CFS symptoms. [18] [19] [20] One strength of this study was the small proportion of patients who were lost to follow-up. The 2 who did not return for long-term follow-up had among the most improved quality of life and function after 6 months, making it unlikely that they had increased impairments in range of motion at the 2-year mark. Although the ROM measurements were made by an examiner who was not blinded as to the diagnosis or length of follow-up, we believe the potential for biased measurement of ROM was small, as 10 of the 11 maneuvers that comprised the ROM score were measured with a goniometer using a standardized technique. Although it is possible that participants became accustomed to the measurements and were more relaxed during the procedures over time, leading to improvements in ROM on that basis, the gradual rate of change in ROM illustrated in the life table analysis argues against a simple or uniform improvement as individuals became more comfortable with the clinic surroundings. We believe these ROM examination maneuvers provide another objective measure that can be used in CFS outcome studies.
Of the 10 participants whose ROM scores did not improve, 7 were unchanged over the study, and 3 worsened. One of the 3 whose ROM score worsened experienced a general improvement on the PedsQL, indicating that ROM improvement was not a necessary accompaniment of overall improvement in CFS symptoms and function. Larger study samples would be needed to determine whether those whose ROM scores worsen have a different course of illness.
Further work is needed to determine the pathophysiology of ROM impairments in CFS. As previously described, these ROM impairments cannot simply be attributed to reductions of activity that occur with the illness, 19 but it is unclear whether they are the consequence of an initiating infection, inflammation in the central nervous system or in the peripheral nerves and their surrounding vasculature and connective tissues, or result from prior injury or comorbid postural dysfunctions such as a head-forward posture. 18, 25 Future studies will have to determine whether improvements in ROM over time can be accelerated by specific forms of physical therapy or certain medications, or are the byproduct of nonspecific improvements in activity. The 2-year followup of this cohort confirms both that the movement restrictions observed at baseline are not fixed, and that, for most individuals, improvement is possible in association with multimodal therapy. ■ 
